REGENXBIO Inc.
Ticker: 1590877
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 6.39-78.5% | 29.73+39.2% | 21.36-76.0% | 89.01+267.8% | 24.20+8.5% | 22.30+42.8% | 15.62-46.0% | 28.91 |
| Total Income | 6.39-78.5% | 29.73+39.2% | 21.36-76.0% | 89.01+267.8% | 24.20+8.5% | 22.30+42.8% | 15.62-46.0% | 28.91 |
| EXPENSES | ||||||||
| Expenditure | 89.76+9.3% | 82.14-3.0% | 84.64+10.1% | 76.89-10.9% | 86.28+10.1% | 78.33-1.5% | 79.49-15.3% | 93.87 |
| PROFIT | ||||||||
| PBT | — | — | — | — | — | — | — | -61.87 |
| Net Profit | -90.05-45.4% | -61.94+12.6% | -70.87-1265.6% | 6.08+110.2% | -59.60-12.5% | -52.99+16.3% | -63.33-2.4% | -61.87 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00%-113.62pp | 13.62%+113.62pp | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00%-106.83pp | 6.83%+106.83pp | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -1.72-43.3% | -1.20+13.0% | -1.38-1250.0% | 0.12+110.3% | -1.17-11.4% | -1.05+23.9% | -1.38+2.1% | -1.41 |
Corporate Events
Board MeetingRGNX
202629May
Board Meeting
2026 Annual Meeting of Stockholders to elect Class II direct…
SEC Filing ↗